Stay updated on Resmetirom Safety and Biomarkers Clinical Trial

Sign up to get notified when there's something new on the Resmetirom Safety and Biomarkers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Resmetirom Safety and Biomarkers Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page version/release label was updated from v3.5.2 to v3.5.3, indicating a site/module revision rather than a change to the ClinicalTrials.gov study record content.
    Difference
    0.0%
    Check dated 2026-04-24T05:51:36.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Added publication citation by Younossi et al. related to MAESTRO Resmetirom trials and updated the page revision from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:25:48.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Removed references to non-alcoholic fatty liver disease and related topics, including MedlinePlus Genetics.
    Difference
    0.1%
    Check dated 2026-04-02T15:25:10.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision updated to v3.5.0; the prior revision, v3.4.3, is no longer displayed.
    Difference
    0.0%
    Check dated 2026-03-19T04:25:03.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T20:15:08.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and a generic funding/operational notice was removed; these are administrative updates to the website. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-11T05:37:30.000Z thumbnail image

Stay in the know with updates to Resmetirom Safety and Biomarkers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Resmetirom Safety and Biomarkers Clinical Trial page.